Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

		Phase:		Phase 1/2

		Treatment ID#:		1548

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed -Unequivocal evidence of progressive disease by MRI or CT scan while on a stable dose of steroids for = 5 days -Failed prior radiotherapy -No more than 3 prior therapies, including initial treatment and treatment for 2 relapses

		Last Updated:		10/03/2007

		Tumor Types:		Anaplastic Astrocytoma Glioblastoma Multiforme Gliosarcoma Mixed Glioma Oligodendroglioma High Grade Oligodendroglioma Low Grade


		Comments:

		Treatment Type:		Chemotherapy

		Contact:		David Reardon MD The Brain Tumor Center at Duke Rm 047 Baker House, Hospital South Trent Drive Durham, NC 27710 USA Phone: (919)684-5301 Fax: (919)684-6674 E-mail: reard003@mc.duke.edu Website: www.cancer.duke.edu/btc

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By